Viewing StudyNCT00654927



Ignite Creation Date: 2024-05-05 @ 7:21 PM
Last Modification Date: 2024-10-26 @ 9:47 AM
Study NCT ID: NCT00654927
Status: COMPLETED
Last Update Posted: 2012-03-02
First Post: 2008-04-04

Brief Title: Open-Label Extension Study to Evaluate the Safety Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis
Sponsor: Acorda Therapeutics
Organization: Acorda Therapeutics

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis
Keywords:
Name View
demyelination View
multiple sclerosis View
MS View
walking View
leg strength View